Fifth largest biopharmaceutical firm created by buy-out
Belgium pharmaceutical firm UCB is to buy Britain's largest biotechnology company Celltech for £1.53bn (€2.26bn).
The move gives UCB access to the fast-growing biotechnology market, creating the world's fifth largest biopharmaceutical company.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





